Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue Gross Profit Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Maze Therapeutics (MAZE) Shares Issued (2024 - 2026)

Maze Therapeutics' Shares Issued history spans 3 years, with the latest figure at $4.1 million for Q1 2026.

On a quarterly basis, Shares Issued rose 3137.3% to $4.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $145.2 million, a 29296.76% increase, with the full-year FY2025 number at $141.3 million, up 19172.44% from a year prior.
Shares Issued hit $4.1 million in Q1 2026 for Maze Therapeutics, up from -$481000.0 in the prior quarter.
Over the last five years, Shares Issued for MAZE hit a ceiling of $141.6 million in Q3 2025 and a floor of -$481000.0 in Q4 2025.
Historically, Shares Issued has averaged $18.3 million across 3 years, with a median of $176000.0 in 2024.
The widest YoY moves for Shares Issued: up 62564.6% in 2025, down 863.49% in 2025.
Tracing MAZE's Shares Issued over 3 years: stood at $63000.0 in 2024, then crashed by 863.49% to -$481000.0 in 2025, then skyrocketed by 948.02% to $4.1 million in 2026.
Business Quant data shows Shares Issued for MAZE at $4.1 million in Q1 2026, -$481000.0 in Q4 2025, and $141.6 million in Q3 2025.